|
SulindacDrug - Sulindac The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Sulindac
Strength -
200MG
Applicant -
CLONMEL HLTHCARE
New Drug Application (NDA) Number -
073262
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 6, 1991
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Clonmel Healthcare Ltd
Sulindac
Gantrisin Eq 4% Base Solution/drops; Ophthalmic
Sulfisoxazole Diolamine Eq 4% Base Solution/drops; Ophthalmic Diasone Sodium 165mg Tablet, Delayed Release; Oral Bensulfoid 33.32% Powder; Topical Clinoril 150mg Tablet; Oral Clinoril 200mg Tablet; Oral Sulindac 150mg Tablet; Oral Sulindac 200mg Tablet; Oral Gantrisin Eq 400mg Base/ml Injectable; Injection Gantrisin Eq 4% Base Ointment; Ophthalmic NewDrugInformation |